Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme
Abstract
:1. Introduction
2. Invasiveness
3. Apoptosis
4. Angiogenesis
5. Proliferation and Immunology
6. High Grade Gliomas and miRNA in the Pediatric Population
6.1. Expression of mRNA in Pediatric and Adult Population
6.2. Tumorgenesis—Similarities and Differences
- Primary—these are tumors that develop rapidly de novo;
- Secondary—these are derived from the evolution of low-grade gliomas that acquire malignancy.
6.3. The Role of Growth Factors
6.4. Epigenetic Nature of Glioblastoma
7. Conclusions
Conflicts of Interest
References
- Banelli, B.; Forlani, A.; Allemanni, G.; Morabito, A.; Pistillo, M.P.; Romani, M. MicroRNA in Glioblastoma: An Overview. Int. J. Genom. 2017, 2017, 7639084. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Crocetti, E.; Trama, A.; Stiller, C.; Caldarella, A.; Soffietti, R.; Jaal, J.; Weber, D.C.; Ricardi, U.; Slowinski, J.; Brandes, A. Epidemiology of glial and non-glial brain tumours in Europe. Eur. J. Cancer 2012, 48, 1532–1542. [Google Scholar] [CrossRef] [PubMed]
- Ohgaki, H.; Kleihues, P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J. Neuropathol. Exp. Neurol. 2005, 64, 479–489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ostrom, Q.T.; Gittleman, H.; Liao, P.; Rouse, C.; Chen, Y.; Dowling, J.; Wolinsky, Y.; Kruchko, C.; Barnholtz-Sloan, J. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro. Oncol. 2014, 16 (Suppl. 4), 1–63. [Google Scholar] [CrossRef] [PubMed]
- Romani, M.; Pistillo, M.P.; Banelli, B. Epigenetic Targeting of Glioblastoma. Front. Oncol. 2018, 8, 448. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Stupp, R.; Mason, W.P.; Van Den Bent, M.J.; Weller, M.; Fisher, B.; Taphoorn, M.J.; Belanger, K.; Brandes, A.A.; Marosi, C.; Bogdahn, U.; et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352, 987–996. [Google Scholar] [CrossRef]
- De Sanctis, V.; Mazzarella, G.; Osti, M.F.; Valeriani, M.; Alfo, M.; Salvati, M.; Banelli, E.; Tombolini, V.; Enrici, R.M. Radiotherapy and sequential temozolomide compared with radiotherapy with concomitant and sequential temozolomide in the treatment of newly diagnosed glioblastoma multiforme. Anti-Cancer Drugs 2006, 17, 969–975. [Google Scholar] [CrossRef]
- Ohgaki, H.; Dessen, P.; Jourde, B.; Horstmann, S.; Nishikawa, T.; Di Patre, P.L.; Burkhard, C.; Schüler, D.; Probst-Hensch, N.M.; Maiorka, P.C.; et al. Genetic pathways to glioblastoma: A population-based study. Cancer Res. 2004, 64, 6892–6899. [Google Scholar] [CrossRef] [Green Version]
- Stupp, R.; Hegi, M.E.; Mason, W.P.; van den Bent, M.J.; Taphoorn, M.J.; Janzer, R.C.; Ludwin, S.K.; Allgeier, A.; Fisher, B.; Belanger, K. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009, 10, 459–466. [Google Scholar] [CrossRef]
- Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W.; et al. Initial sequencing and analysis of the human genome. Nature 2001, 409, 860–921. [Google Scholar]
- Zhang, Y.; Yang, P.; Sun, T.; Li, D.; Xu, X.; Rui, Y.; Li, C.; Chong, M.; Ibrahim, T.; Mercatali, L.; et al. miR-126 and miR-126 repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nat. Cell. Biol. 2013, 15, 284–294. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ambros, V. The functions of animal microRNAs. Nature 2004, 431, 350–355. [Google Scholar] [CrossRef] [PubMed]
- Bartel, D.P. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004, 116, 281–297. [Google Scholar] [CrossRef] [Green Version]
- Bartel, D.P. Metazoan MicroRNAs. Cell 2018, 173, 20–51. [Google Scholar] [CrossRef] [PubMed]
- Lee, Y.; Kim, M.; Han, J.; Yeom, K.H.; Lee, S.; Baek, S.H.; Kim, V.N. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23, 4051–4060. [Google Scholar] [CrossRef] [PubMed]
- Zhou, X.; Ruan, J.; Wang, G.; Zhang, W. Characterization and identification of microRNA core promoters in four model species. PLoS Comput. Biol. 2007, 3, e37. [Google Scholar] [CrossRef] [PubMed]
- Fromm, B.; Billipp, T.; Peck, L.E.; Johansen, M.; Tarver, J.E.; King, B.L.; Newcomb, J.M.; Sempere, L.F.; Flatmark, K.; Hovig, E. A Uniform System for the Annotation of Vertebrate microRNA Genes and the Evolution of the Human microRNAome. Annu. Rev. Genet. 2015, 49, 213–242. [Google Scholar] [CrossRef] [Green Version]
- Griffiths-Jones, S. The microRNA Registry. Nucleic Acids Res. 2004, 32, D109–D111. [Google Scholar] [CrossRef]
- Lewis, B.P.; Burge, C.B.; Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120, 15–20. [Google Scholar] [CrossRef] [Green Version]
- González-Gómez, P.; Sánchez, P.; Mira, H. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme. Mol. Neurobiol. 2011, 44, 235–249. [Google Scholar] [CrossRef]
- Berindan-Neagoe, I.; Monroig Pdel, C.; Pasculli, B.; Calin, G.A. MicroRNAome genome: A treasure for cancer diagnosis and therapy. CA Cancer J. Clin. 2014, 64, 311–336. [Google Scholar] [CrossRef] [PubMed]
- Calin, G.A.; Sevignani, C.; Dumitru, C.D.; Hyslop, T.; Noch, E.; Yendamuri, S.; Shimizu, M.; Rattan, S.; Bullrich, F.; Negrini, M.; et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2014, 101, 2999–3004. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hummel, R.; Maurer, J.; Haier, J. MicroRNAs in brain tumors: A new diagnostic and therapeutic perspective? Mol. Neurobiol. 2011, 44, 223–234. [Google Scholar] [CrossRef] [PubMed]
- Vella, M.C.; Choi, E.Y.; Lin, S.Y.; Reinert, K.; Slack, F.J. The C. elegans microRNA let-7 binds to imperfect let-7 complementary sites from the lin-41 3′UTR. Genes Dev. 2004, 18, 132–137. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kawamata, T.; Yoda, M.; Tomari, Y. Multilayer checkpoints for microRNA authenticity during RISC assembly. EMBO Rep. 2011, 12, 944–949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shea, A.; Harish, V.; Afzal, Z.; Chijioke, J.; Kedir, H.; Dusmatova, S.; Roy, A.; Ramalinga, M.; Harris, B.; Blancato, J.; et al. MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics. Cancer Med. 2016, 5, 1917–1946. [Google Scholar] [CrossRef] [PubMed]
- Møller, H.G.; Rasmussen, A.P.; Andersen, H.H.; Johnsen, K.B.; Henriksen, M.; Duroux, M. A systematic review of microRNA in glioblastoma multiforme: Micro-modulators in the mesenchymal mode of migration and invasion. Mol. Neurobiol. 2013, 47, 131–144. [Google Scholar] [CrossRef] [Green Version]
- Ahir, B.K.; Ozer, H.; Engelhard, H.H.; Lakka, S.S. MicroRNAs in glioblastoma pathogenesis and therapy: A comprehensive review. Crit. Rev. Oncol. Hematol. 2017, 120, 22–33. [Google Scholar] [CrossRef]
- Godlewski, J.; Nowicki, M.O.; Bronisz, A.; Williams, S.; Otsuki, A.; Nuovo, G.; Raychaudhury, A.; Newton, H.B.; Chiocca, E.A.; Lawler, S. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 2008, 68, 9125–9130. [Google Scholar] [CrossRef] [Green Version]
- Lawler, S.; Chiocca, E.A. Emerging functions of microRNAs in glioblastoma. J. Neurooncol. 2009, 92, 297–306. [Google Scholar] [CrossRef]
- Silber, J.; Lim, D.A.; Petritsch, C.; Persson, A.I.; Maunakea, A.K.; Yu, M.; Vandenberg, S.R.; Ginzinger, D.G.; James, C.D.; Costello, J.F.; et al. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6, 14. [Google Scholar] [CrossRef] [PubMed]
- Li, J.; Zhang, P.; Hui, N. MiR-218 impairs tumor growth and increases chemo-sensitivity to cisplatin in cervical cancer. International journal of molecular sciences. Int. J. Mol. Sci. 2012, 13, 16053–16064. [Google Scholar] [CrossRef] [PubMed]
- Ciafrè, S.A.; Galardi, S.; Mangiola, A.; Ferracin, M.; Liu, C.G.; Sabatino, G.; Negrini, M.; Maira, G.; Croce, C.M.; Farace, M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334, 1351–1358. [Google Scholar] [CrossRef] [PubMed]
- Chan, J.A.; Krichevsky, A.M.; Kosik, K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65, 6029–6033. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, Q.; Li, P.; Li, A.; Jiang, W.; Wang, H.; Wang, J.; Xie, K. Plasma specifc miRNAs as predictive biomarkers for diagnosis and prognosis of glioma. J. Exp. Clin. Cancer Res. 2012, 31, 97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- De Smaele, E.; Ferretti, E.; Gulino, A. MicroRNAs as biomarkers for CNS cancer and other disorders. Brain Res. 2010, 1338, 100–111. [Google Scholar] [CrossRef]
- Yang, G.; Zhang, R.; Chen, X.; Mu, Y.; Ai, J.; Shi, C.; Liu, Y.; Shi, C.; Sun, L.; Rainov, N.G.; et al. MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J. Mol. Med. 2011, 89, 1037–1050. [Google Scholar] [CrossRef]
- Huse, J.T.; Brennan, C.; Hambardzumyan, D.; Wee, B.; Pena, J.; Rouhanifard, S.H.; Sohn-Lee, C.; le Sage, C.; Agami, R.; Tuschl, T.; et al. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev. 2009, 23, 1327–1337. [Google Scholar] [CrossRef] [Green Version]
- Hermansen, S.K.; Dahlrot, R.H.; Nielsen, B.S.; Hansen, S.; Kristensen, B.W. MiR-21 expression in the tumor cell compartment holds unfavourable prognostic value in gliomas. J. Neurooncol. 2013, 111, 71–81. [Google Scholar] [CrossRef]
- Corsten, M.F.; Miranda, R.; Kasmieh, R.; Krichevsky, A.M.; Weissleder, R.; Shah, K. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res. 2007, 67, 8994–9000. [Google Scholar] [CrossRef] [Green Version]
- Wu, Z.; Sun, L.; Wang, H.; Yao, J.; Jiang, C.; Xu, W.; Yang, Z. MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma. PLoS ONE 2012, 7, e47270. [Google Scholar] [CrossRef] [PubMed]
- Jiang, J.; Sun, X.; Wang, W.; Jin, X.; Bo, X.; Li, Z.; Bian, A.; Jiu, J.; Wang, X.; Liu, D.; et al. Tumor microRNA-335 expression is associated with poor prognosis in human glioma. Med. Oncol. 2012, 29, 3472–3477. [Google Scholar] [CrossRef] [PubMed]
- Conti, A.; Aguennouz, M.; La Torre, D.; Tomasello, C.; Cardali, S.; Angileri, F.F.; Maio, F.; Cama, A.; Germanò, A.; Vita, G.; et al. miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neurooncol. 2009, 93, 325–332. [Google Scholar] [CrossRef] [PubMed]
- Kefas, B.; Godlewski, J.; Comeau, L.; Li, Y.; Abounader, R.; Hawkinson, M.; Lee, J.; Fine, H.; Chiocca, E.A.; Lawler, S.; et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 2008, 68, 3566–3572. [Google Scholar] [CrossRef] [Green Version]
- Shi, L.; Cheng, Z.; Zhang, J.; Li, R.; Zhao, P.; Fu, Z.; You, Y. hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 2008, 1236, 185–193. [Google Scholar] [CrossRef]
- Kong, D.; Li, Y.; Wang, Z.; Sarkar, F.H. Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins? Cancers 2011, 3, 716–729. [Google Scholar] [CrossRef]
- Lamouille, S.; Xu, J.; Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 2014, 15, 178–196. [Google Scholar] [CrossRef] [Green Version]
- Kalluri, R.; Weinberg, R.A. The basics of epithelial-mesenchymal transition. J. Clin. Investig. 2009, 119, 1420–1428. [Google Scholar] [CrossRef] [Green Version]
- Thiery, J.P.; Sleeman, J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol. 2006, 7, 131–142. [Google Scholar] [CrossRef]
- Hanahan, D.; Weinberg, R. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674. [Google Scholar] [CrossRef] [Green Version]
- Harazono, Y.L.; Muramatsu, T.; Endo, H.; Uzawa, N.; Kawano, T.; Harada, K.; Inazawa, J.; Kozaki, K. miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2. PLoS ONE 2013, 8, e62757. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gabriely, G.; Wurdinger, T.; Kesari, S.; Esau, C.C.; Burchard, J.; Linsley, P.S.; Krichevsky, A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 2008, 28, 5369–5380. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, Y.; Wang, Y.; Yu, L.; Sun, C.; Cheng, D.; Yu, S.; Wang, Q.; Yan, Y.; Kang, C.; Jin, S.; et al. miR-146b-5p inhibits glioma migration and invasion by targeting MMP16. Cancer Lett. 2013, 339, 260–269. [Google Scholar] [CrossRef] [PubMed]
- Cui, B.; Li, B.; Liu, Q.; Cui, Y. lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b. J. Cell. Biochem. 2017, 118, 4548–4557. [Google Scholar] [CrossRef]
- Sun, L.; Yan, W.; Wang, Y.; Sun, G.; Luo, H.; Zhang, J.; Wang, X.; You, Y.; Yang, Z.; Liu, N. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011, 1389, 9–18. [Google Scholar] [CrossRef] [PubMed]
- Wu, D.G.; Wang, Y.Y.; Fan, L.G.; Luo, H.; Han, B.; Sun, L.H.; Wang, X.F.; Zhang, J.X.; Cao, L.; Wang, X.R.; et al. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin. Med. J. 2011, 124, 2616–2621. [Google Scholar]
- Lin, J.S.; Teo, D.H.; Lam, K.; Jeyaseelan, K.; Wang, S. MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. Cell Death Dis. 2012, 3, e398. [Google Scholar] [CrossRef]
- Liao, H.; Bai, Y.; Qiu, S.; Zheng, L.; Huang, L.; Liu, T.; Wang, X.; Liu, Y.; Xu, N.; Yan, X.; et al. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget 2015, 6, 8914–8928. [Google Scholar] [CrossRef]
- Carlson, B.M. Human Embryology and Developmental Biology, 5th ed.; Elsevier Health Sciences: Philadelphia, PA, USA, 2013; pp. 101–102, 106, 313, 362, 382. [Google Scholar]
- Nieto, M.A. The snail superfamily of zinc-finger transcription factors. Nat. Rev. Mol. Cell. Biol. 2012, 3, 155–166. [Google Scholar] [CrossRef]
- Inukai, T.; Inoue, A.; Kurosawa, H.; Goi, K.; Shinjyo, T.; Ozawa, K.; Mao, M.; Inaba, T.; Look, A.T. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol. Cell 1999, 4, 343–352. [Google Scholar] [CrossRef]
- Chang, T.H.; Tsai, M.F.; Su, K.Y.; Wu, S.G.; Huang, C.P.; Yu, S.L.; Yu, Y.L.; Lan, C.C.; Yang, C.H.; Lin, S.B.; et al. Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor. Am. J. Respir. Crit. Care Med. 2011, 183, 1071–1079. [Google Scholar] [CrossRef] [PubMed]
- Shih, J.Y.; Yang, P.C. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011, 32, 1299–1304. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chang, C.; Chao, C.; Xia, W.; Yang, J.; Xiong, Y.; Li, C.; Yu, W.; Rehman, S.K.; Hsu, J.L.; Lee, H.; et al. p53 regulates epithelial-mesenchymal transition (EMT) and stem cell properties through modulating miRNAs. Nat. Cell Biol. 2011, 13, 317–323. [Google Scholar] [CrossRef] [PubMed]
- Snoek-van Beurden, P.A.M.; Von den Hoff, J.W. Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors. Biotechniques 2015, 38, 73–83. [Google Scholar] [CrossRef] [Green Version]
- Verma, R.P.; Hansch, C. Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 2007, 15, 2223–2268. [Google Scholar] [CrossRef]
- Ellerbroek, S.M.; Halbleib, J.M.; Benavidez, M.; Warmka, J.K.; Wattenberg, E.V.; Stack, M.S.; Hudson, L.G. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloprotein-ase-9 production and cell surface association. Cancer Res. 2001, 61, 1855–1861. [Google Scholar]
- Kesanakurti, D.; Chetty, C.; Maddirela, D.R.; Gujrati, M.; Rao, J.S. Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma. Cell Death Dis. 2012, 3, e445. [Google Scholar] [CrossRef] [Green Version]
- Litak, J.; Mazurek, M.; Grochowski, C.; Kamieniak, P.; Roliński, J. PD-L1/PD-1 Axis in Glioblastoma Multiforme. Int. J. Mol. Sci. 2019, 20, 5347. [Google Scholar] [CrossRef] [Green Version]
- Choe, G.; Park, J.K.; Jouben-Steele, L.; Kremen, T.J.; Liau, L.M.; Vinters, H.V.; Cloughesy, T.F.; Mischel, P.S. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin. Cancer Res. 2002, 8, 2894–2901. [Google Scholar]
- Anand, M.; Van Meter, T.E.; Fillmore, H.L. Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway. J. Neuro Oncol. 2011, 104, 679–687. [Google Scholar] [CrossRef]
- Papagiannakopoulos, T.; Shapiro, A.; Kosik, K.S. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Cancer Res. 2008, 68, 8164–8172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schramedei, K.; Mörbt, N.; Pfeifer, G.; Läuter, J.; Rosolowski, M.; Tomm, J.M.; von Bergen, M.; Horn, F.; Brocke-Heidrich, K. MicroRNA-21 targets tumor suppressor genes ANP32A and SMARCA4. Oncogene 2011, 30, 2975–2985. [Google Scholar] [CrossRef] [Green Version]
- Kwak, H.J.; Kim, Y.J.; Chun, K.R.; Woo, Y.M.; Park, S.J.; Jeong, J.A.; Jo, S.H.; Kim, T.H.; Min, H.S.; Chae, J.S.; et al. Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas. Oncogene 2011, 30, 2433–2442. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, C.; Li, C.; Li, J.; Han, J.; Shang, D.; Zhang, Y.; Zhang, W.; Yao, Q.; Han, L.; Xu, Y.; et al. Identification of miRNA-mediated core gene module for glioma patient prediction by integrating high-throughput miRNA, mRNA expression and pathway structure. PLoS ONE 2014, 9, e96908. [Google Scholar] [CrossRef] [PubMed]
- Chou, C.K.; Chen, R.F.; Chou, F.F.; Chang, H.W.; Chen, Y.J.; Lee, Y.F.; Yang, K.D.; Cheng, J.T.; Huang, C.C.; Liu, R.T. miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 2010, 20, 489–494. [Google Scholar] [CrossRef] [PubMed]
- Hurst, D.R.; Edmonds, M.D.; Scott, G.K.; Benz, C.C.; Vaidya, K.S.; Welch, D.R. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69, 1279–1283. [Google Scholar] [CrossRef] [Green Version]
- Xia, H.; Qi, Y.; Ng, S.S.; Chen, X.; Li, D.; Chen, S.; Ge, R.; Jiang, S.; Li, G.; Chen, Y.; et al. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res. 2009, 1269, 158–165. [Google Scholar] [CrossRef]
- Zheng, J.; Liu, X.; Wang, P.; Xue, Y.; Ma, J.; Qu, C.; Liu, Y. CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis. Mol. Ther. J. Am. Soc. Gene Ther. 2016, 24, 1199–1215. [Google Scholar] [CrossRef] [Green Version]
- Liu, X.; Wang, S.; Yuan, A.; Yuan, X.; Liu, B. MicroRNA-140 represses glioma growth and metastasis by directly targeting ADAM9. Oncol. Rep. 2016, 36, 2329–2338. [Google Scholar] [CrossRef]
- Asuthkar, S.; Velpula, K.K.; Chetty, C.; Gorantla, B.; Rao, J.S. Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity. Oncotarget 2012, 3, 1439–1454. [Google Scholar] [CrossRef] [Green Version]
- Hu, Y.; Li, Y.; Wu, C.; Zhou, L.; Han, X.; Wang, Q.; Xie, X.; Zhou, Y.; Du, Z. MicroRNA-140-5p inhibits cell proliferation and invasion by regulating VEGFA/MMP2 signaling in glioma. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2017, 39, 1010428317697558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zheng, X.; Chopp, M.; Lu, Y.; Buller, B.; Jiang, F. MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. Cancer Lett. 2013, 329, 146–154. [Google Scholar] [CrossRef] [Green Version]
- Chen, L.; Chen, X.R.; Chen, F.F.; Liu, Y.; Li, P.; Zhang, R.; Yan, K.; Yi, Y.J.; Xu, Z.M.; Jiang, X.D. MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell. Mol. Neurobiol. 2013, 33, 651–657. [Google Scholar] [CrossRef]
- Chen, L.; Chen, X.R.; Zhang, R.; Li, P.; Liu, Y.; Yan, K.; Jiang, X.D. MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression. J. Neuro Oncol. 2013, 112, 59–66. [Google Scholar] [CrossRef] [PubMed]
- Wang, W.; Dai, L.X.; Zhang, S.; Yang, Y.; Yan, N.; Fan, P.; Dai, L.; Tian, H.W.; Cheng, L.; Zhang, X.M.; et al. Regulation of epidermal growth factor receptor signaling by plasmid-based microRNA-7 inhibits human malignant gliomas growth and metastasis in vivo. Neoplasma 2013, 60, 274–283. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.; Liu, Y.; Li, L.; Xu, Z.; Bi, B.; Wang, Y.; Li, J.Y. MiR-7-5p is frequently downregulated in glioblastoma microvasculature and inhibits vascular endothelial cell proliferation by targeting raf1. Tumor Biol. 2014, 35, 10177–10184. [Google Scholar] [CrossRef]
- Lu, Z.J.; Liu, S.Y.; Yao, Y.Q.; Zhou, Y.J.; Zhang, S.; Dai, L.; Tian, H.W.; Zhou, Y.; Deng, H.X.; Yang, J.L.; et al. The effect of miR-7 on behavior and global protein expression in glioma cell lines. Electrophoresis 2011, 32, 3612–3620. [Google Scholar] [CrossRef]
- Herbst, R.S. Review of epidermal growth factor receptor biology. Int. J. Radiat. Oncol. Biol. Phys. 2004, 59 (Suppl. 2), 21–26. [Google Scholar] [CrossRef]
- Oda, K.; Matsuoka, Y.; Funahashi, A.; Kitano, H. A comprehensive pathway map of epidermal growth factor receptor signaling. Mol. Syst. Biol. 2005, 1, E1–E17. [Google Scholar] [CrossRef] [Green Version]
- Lynch, T.J.; Bell, D.W.; Sordella, R.; Gurubhagavatula, S.; Okimoto, R.A.; Brannigan, B.W.; Harris, P.L.; Haserlat, S.M.; Supko, J.G.; Haluska, F.G.; et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib (PDF). N. Engl. J. Med. 2004, 350, 2129–2139. [Google Scholar] [CrossRef]
- Watanabe, K.; Tachibana, O.; Sata, K.; Yonekawa, Y.; Kleihues, P.; Ohgaki, H. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 1996, 6, 217–223. [Google Scholar] [CrossRef]
- Kuan, C.T.; Wikstrand, C.J.; Bigner, D.D. EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr. Relat. Cancer 2001, 8, 83–96. [Google Scholar] [CrossRef] [Green Version]
- Guillamo, J.-S.; Valable, S.; Marteau, L.; Leuraud, P.; Marie, Y.; Poupon, M.-F.; Parienti, J.-J.; Raymond, E.; Peschanski, M.; De Boüard, S. Molecular Mechanisms Underlying Effects of Epidermal Growth Factor Receptor Inhibition on Invasion, Proliferation, and Angiogenesis in Experimental Glioma. Clin. Cancer Res. 2009, 15, 3697–3704. [Google Scholar] [CrossRef] [Green Version]
- Huang, P.H.; Mukasa, A.; Bonavia, R.; Flynn, R.A.; Brewer, Z.E.; Cavenee, W.K.; Furnari, F.B.; White, F.M. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc. Natl. Acad. Sci. USA 2007, 104, 12867–12872. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bonavia, R.; Inda, M.; Vandenberg, S.; Cheng, S.; Nagane, M.; Hadwiger, P.; Tan, P.; Sah, D.; Cavenee, W.; Furnari, F. EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathway. Oncogene 2012, 31, 4054–4066. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shibata, T.; Kawano, T.; Nagayasu, H.; Okumura, K.; Arisue, M.; Hamada, J.-I.; Takeichi, N.; Hosokawa, M. Enhancing effects of epidermal growth factor on human squamous cell carcinoma motility and matrix degradation but not growth. Tumor Boil. 1996, 17, 168–175. [Google Scholar] [CrossRef] [PubMed]
- Price, J.; Wilson, H.; Haites, N. Epidermal growth factor (EGF) Increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer 1996, 32, 1977–1982. [Google Scholar] [CrossRef]
- Surget, S.; Khoury, M.P.; Bourdon, J.C. Uncovering the role of p53 splice variants in human malignancy: A clinical perspective. Onco Targets Ther. 2013, 7, 57–68. [Google Scholar] [CrossRef] [Green Version]
- Stiewe, T. The p53 family in differentiation and tumorigenesis. Nat. Rev. Cancer 2007, 7, 165–167. [Google Scholar] [CrossRef]
- Lin, L.; Ozaki, T.; Takada, Y.; Kageyama, H.; Nakamura, Y.; Hata, A.; Zhang, J.H.; Simonds, W.F.; Nakagawara, A.; Koseki, H. topors, a p53 and topoisomerase I-binding RING finger protein, is a coactivator of p53 in growth suppression induced by DNA damage. Oncogene 2005, 24, 3385–3396. [Google Scholar] [CrossRef] [Green Version]
- Li, Q.; Wang, X.; Wu, X.; Rui, Y.; Liu, W.; Wang, J.; Wang, X.; Liou, Y.C.; Ye, Z.; Lin, S.C. Daxx Cooperates with the Axin/HIPK2/p53 complex to induce cell death. Cancer Res. 2007, 67, 66–74. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moumen, A.; Masterson, P.; O’Connor, M.J.; Jackson, S.P. hnRNP K: An HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 2005, 123, 1065–1078. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Coutts, A.S.; La Thangue, N.B. The p53 response: Emerging levels of co-factor complexity. Biochem. Biophys. Res. Commun. 2005, 331, 778–785. [Google Scholar] [CrossRef] [PubMed]
- Bullock, A.N.; Fersht, A.R. Rescuing the function of mutant p53. Nat. Rev. Cancer 2001, 1, 68–76. [Google Scholar] [CrossRef]
- Galluzzi, L.; López-Soto, A.; Kumar, S.; Kroemer, G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity 2016, 44, 221–231. [Google Scholar] [CrossRef] [Green Version]
- Zhou, X.; Zhang, J.; Jia, Q.; Ren, Y.; Wang, Y.; Shi, L.; Liu, N.; Wang, G.; Pu, P.; You, Y.; et al. Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol. Rep. 2010, 24, 195–201. [Google Scholar]
- Kouri, F.M.; Ritner, C.; Stegh, A.H. miRNA-182 and the regulation of the glioblastoma phenotype—Toward miRNA-based precision therapeutics. Cell Cycle 2015, 14, 3794–3800. [Google Scholar] [CrossRef] [Green Version]
- Zheng, J.; Li, X.D.; Wang, P.; Liu, X.B.; Xue, Y.X.; Hu, Y.; Li, Z.; Li, Z.Q.; Wang, Z.H.; Liu, Y.H. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186. Oncotarget 2015, 6, 25339–25355. [Google Scholar] [CrossRef]
- He, J.; Zhang, W.; Zhou, Q.; Zhao, T.; Song, Y.; Chai, L.; Li, Y. Low-expression of microRNA-107 inhibits cell apoptosis in glioma by upregulation of SALL4. Int. J. Biochem. Cell Biol. 2013, 45, 1962–1973. [Google Scholar]
- Nakano, K.; Vousden, K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 2001, 7, 683–694. [Google Scholar] [CrossRef]
- Zhao, Y.; Coloff, J.L.; Ferguson, E.C.; Jacobs, S.R.; Cui, K.; Rathmell, J.C. Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J. Biol. Chem. 2008, 283, 36344–36353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zhang, C.; Zhang, J.; Zhang, A.-L.; Shi, Z.; Han, L.; Jia, Z.; Yang, W.-D.; Wang, G.-X.; Jiang, T.; You, Y.; et al. MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol. Cancer 2010, 9, 229. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, L.; Zhang, J.; Han, L.; Zhang, A.; Zhang, C.; Zheng, Y.; Jiang, T.; Pu, P.; Jiang, C.; Kang, C. Downregulation of miR-221/222 sensitizes glioma cells to temozolomide by regulating apoptosis independently of p53 status. Oncol. Rep. 2012, 27, 854–860. [Google Scholar] [PubMed]
- Shu, M.; Zheng, X.; Wu, S.; Lu, H.; Leng, T.; Zhu, W.; Zhou, Y.; Ou, Y.; Lin, X.; Lin, Y.; et al. Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol. Cancer 2011, 10, 59. [Google Scholar] [CrossRef] [Green Version]
- Comincini, S.; Allavena, G.; Palumbo, S.; Morini, M.; Durando, F.; Angeletti, F.; Pirtoli, L.; Miracco, C. microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells. Cancer Biol. Ther. 2013, 14, 574–586. [Google Scholar] [CrossRef]
- Grochowski, C.; Staśkiewicz, G. Ultra high field TOF-MRA: A method to visualize small cerebral vessels. 7 T TOF-MRA sequence parameters on different MRI scanners—Literature review. Neurol. Neurochir. Pol. 2017, 51, 411–418. [Google Scholar] [CrossRef]
- Krishnan, S.; Szabo, E.; Burghardt, I.; Frei, K.; Tabatabai, G.; Weller, M. Modulation of cerebral endothe-lial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchy-mal transition. Oncotarget 2015, 6, 22480–22495. [Google Scholar] [CrossRef] [Green Version]
- Keller, S.; Schmidt, M.H.H. EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblasto-ma: Combination Therapies for an Effective Treatment. Int. J. Mol. Sci. 2017, 18, 1295. [Google Scholar] [CrossRef] [Green Version]
- Hardee, M.E.; Zagzag, D. Mechanisms of glioma-associated neovascularization. Am. J. Pathol. 2012, 181, 1126–1141. [Google Scholar] [CrossRef] [Green Version]
- Wang, S.; Olson, E.N. AngiomiRs—Key regulators of angiogenesis. Curr. Opin. Genet Dev. 2009, 19, 205–211. [Google Scholar] [CrossRef] [Green Version]
- Kaur, B.; Khwaja, F.W.; Severson, E.A.; Matheny, S.L.; Brat, D.J.; Van Meir, E.G. Hypoxia and the hy-poxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol. 2005, 7, 134–153. [Google Scholar] [CrossRef] [Green Version]
- Weathers, S.P.; de Groot, J. VEGF Manipulation in Glioblastoma. Oncology 2015, 29, 720–727. [Google Scholar]
- Shimizu, A.; Nakayama, H.; Wang, P.; Konig, C.; Akino, T.; Sandlund, J.; Coma, S.; Italiano, J.E., Jr.; Mammoto, A.; Bielenberg, D.R.; et al. Netrin-1 promotes glioblastoma cell invasiveness and angiogenesis by multiple pathways including activation of RhoA, cathepsin B, and cAMP-response element-binding protein. J. Biol. Chem. 2013, 288, 2210–2222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jain, R.K.; di Tomaso, E.; Duda, D.G.; Loeffler, J.S.; Sorensen, A.G.; Batchelor, T.T. Angiogenesis in brain tumours. Nat. Rev. Neurosci. 2007, 8, 610–622. [Google Scholar] [CrossRef] [PubMed]
- Knizhnik, A.V.; Roos, W.P.; Nikolova, T.; Quiros, S.; Tomaszowski, K.H.; Christmann, M.; Kaina, B. Survival and death strategies in glioma cells: Autophagy, senescence and apoptosis triggered by a single type of temozolomide-induced DNA damage. PLoS ONE 2013, 8, e55665. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mazurek, M.; Litak, J.; Kamieniak, P.; Kulesza, B.; Jonak, K.; Baj, J.; Grochowski, C. Metformin as Potential Therapy for High-Grade Glioma. Cancers 2020, 12, 210. [Google Scholar] [CrossRef] [Green Version]
- Wilkins, S.E.; Abboud, M.I.; Hancock, R.L.; Schofield, C.J. Targeting Protein-Protein Interactions in the HIF System. ChemMedChem 2016, 11, 773–786. [Google Scholar] [CrossRef]
- Smith, T.G.; Robbins, P.A.; Ratcliffe, P.J. The human side of hypoxia-inducible factor. Br. J. Haematol. 2008, 141, 325–334. [Google Scholar] [CrossRef]
- Huang, W.J.; Chen, W.W.; Zhang, X. Glioblastoma multiforme: Effect of hypoxia and hypoxia inducible factors on therapeutic approaches. Oncol. Lett. 2016, 12, 2283–2288. [Google Scholar] [CrossRef]
- Iwadate, Y. Epithelial-mesenchymal transition in glioblastoma progression. Oncol. Lett. 2016, 11, 1615–1620. [Google Scholar] [CrossRef] [Green Version]
- Fischbach, C.; Kong, H.J.; Hsiong, S.X.; Evangelista, M.B.; Yuen, W.; Mooney, D.J. Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc. Natl. Acad. Sci. USA 2009, 106, 399–404. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hermansen, S.K.; Nielsen, B.S.; Aaberg-Jessen, C.; Kristensen, B.W. miR-21 Is Linked to Glioma Angiogenesis: A Co-Localization Study. J. Histochem. Cytochem. 2016, 64, 138–148. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Shi, Z.M.; Wang, J.; Yan, Z.; You, Y.P.; Li, C.Y.; Qian, X.; Yin, Y.; Zhao, P.; Wang, Y.Y.; Wang, X.F.; et al. MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. PLoS ONE 2012, 7, e32709. [Google Scholar] [CrossRef] [PubMed]
- Wang, L.; Shi, Z.M.; Jiang, C.F.; Liu, X.; Chen, Q.D.; Qian, X.; Li, D.M.; Ge, X.; Wang, X.F.; Liu, L.Z.; et al. MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomideinduced apoptosis in glioma. Oncotarget 2014, 5, 5416–5427. [Google Scholar] [CrossRef] [Green Version]
- Agrawal, R.; Pandey, P.; Jha, P.; Dwivedi, V.; Sarkar, C.; Kulshreshtha, R. Hypoxic signature of microRNAs in glioblastoma: Insights from small RNA deep sequencing. BMC Genom. 2014, 15, 686. [Google Scholar] [CrossRef] [Green Version]
- Wurdinger, T.; Tannous, B.A.; Saydam, O.; Skog, J.; Grau, S.; Soutschek, J.; Weissleder, R.; Breakefield, X.O.; Krichevsky, A.M. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008, 14, 382–393. [Google Scholar] [CrossRef] [Green Version]
- Smits, M.; Wurdinger, T.; van het Hof, B.; Drexhage, J.A.; Geerts, D.; Wesseling, P.; Noske, D.P.; Vandertop, W.P.; de Vries, H.E.; Reijerkerk, A. Mycassociated zinc fnger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J. 2012, 26, 2639–2647. [Google Scholar] [CrossRef]
- Ma, Y.; Xue, Y.; Liu, X.; Qu, C.; Cai, H.; Wang, P.; Li, Z.; Li, Z.; Liu, Y. SNHG15 affects the growth of glioma microvascular endothelial cells by negatively regulating miR-153. Oncol. Rep. 2017, 38, 3265–3277. [Google Scholar] [CrossRef] [Green Version]
- Chen, L.; Li, Z.Y.; Xu, S.Y.; Zhang, X.J.; Zhang, Y.; Luo, K.; Li, W.P. Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression. Cell. Mol. Neurobiol. 2016, 36, 113–120. [Google Scholar] [CrossRef]
- Fang, L.; Deng, Z.; Shatseva, T.; Yang, J.; Peng, C.; Du, W.W.; Yee, A.J.; Ang, L.C.; He, C.; Shan, S.W.; et al. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 2011, 30, 806–821. [Google Scholar] [CrossRef] [Green Version]
- Tchaicha, J.H.; Reyes, S.B.; Shin, J.; Hossain, M.G.; Lang, F.F.; McCarty, J.H. Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin. Cancer Res. 2011, 71, 6371–6381. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bonauer, A.; Dimmeler, S. The microRNA-17-92 cluster: Still a miRacle? Cell Cycle 2009, 8, 3866–3873. [Google Scholar] [CrossRef] [PubMed]
- Jia, P.; Cai, H.; Liu, X.; Chen, J.; Ma, J.; Wang, P.; Liu, Y.; Zheng, J.; Xue, Y. Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a. Cancer Lett. 2016, 381, 359–369. [Google Scholar] [CrossRef] [PubMed]
- Tili, E.; Michaille, J.-J.; Wernicke, R.; Alder, H.; Costinean, S.; Volinia, S.; Croce, C.M. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc. Natl. Acad. Sci. USA 2011, 108, 4908–4913. [Google Scholar] [CrossRef] [Green Version]
- Ma, Y.; Wang, P.; Xue, Y.; Qu, C.; Zheng, J.; Liu, X.; Ma, J.; Liu, Y. PVT1 affects growth of glioma microvascular endothelial cells by negatively regulating miR-186. Tumor Biol. 2017, 39, 1010428317694326. [Google Scholar] [CrossRef] [Green Version]
- Cheng, Z.; Li, Z.; Ma, K.; Li, X.; Tian, N.; Duan, J.; Xiao, X.; Wang, Y. Long Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429. J. Cancer 2017, 8, 4106–4116. [Google Scholar] [CrossRef]
- Lo Dico, A.; Costa, V.; Martelli, C.; Diceglie, C.; Rajata, F.; Rizzo, A.; Mancone, C.; Tripodi, M.; Ottobrini, L.; Alessandro, R.; et al. MiR675-5p Acts on HIF-1alpha to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma. Theranostics 2016, 6, 1105–1118. [Google Scholar] [CrossRef] [Green Version]
- Kyriakis, J.M. The integration of signaling by multiprotein complexes containing Raf kinases. Biochim. Biophys. Acta 2007, 1773, 1238–1247. [Google Scholar] [CrossRef] [Green Version]
- Von Kriegsheim, A.; Pitt, A.; Grindlay, G.J.; Kolch, W.; Dhillon, A.S. Regulation of the Raf-MEK-ERK pathway by protein phosphatase 5. Nat. Cell Biol. 2006, 8, 1011–1016. [Google Scholar] [CrossRef]
- McPhillips, F.; Mullen, P.; MacLeod, K.; Sewell, J.M.; Monia, B.P.; Cameron, D.A.; Smyth, J.F.; Langdon, S.P. Raf-1 is the predominant Raf isoform that mediates growth factor-stimulated growth in ovarian cancer cells. Carcinogenesis 2005, 27, 729–739. [Google Scholar] [CrossRef] [Green Version]
- Fushimi, K.; Nakashima, S.; You, F.; Takigawa, M.; Shimizu, K. Prostaglandin E2 downregulates TNF-alpha-induced production of matrix metalloproteinase-1 in HCS-2/8 chondrocytes by inhibiting Raf-1/MEK/ERK cascade through EP4 prostanoid receptor activation. J. Cell Biochem. 2007, 100, 783–793. [Google Scholar] [CrossRef]
- Pal, A.; Ahmad, A.; Khan, S.; Sakabe, I.; Zhang, C.; Kasid, U.N.; Ahmad, I. Systemic delivery of RafsiRNA using cationic cardiolipin liposomes silences Raf-1 expression and inhibits tumor growth in xenograft model of human prostate cancer. Int. J. Oncol. 2005, 26, 1087–1091. [Google Scholar] [CrossRef] [PubMed]
- Leicht, D.T.; Balan, V.; Kaplun, A.; Singh-Gupta, V.; Kaplun, L.; Dobson, M.; Tzivion, G. Raf kinases: Function, regulation and role in human cancer. Biochim. Biophys. Acta BBA Bioenerg. 2007, 1773, 1196–1212. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zebisch, A.; Troppmair, J. Back to the roots: The remarkable RAF oncogene story. Cell Mol. Life Sci. 2006, 63, 1314–1330. [Google Scholar] [CrossRef] [PubMed]
- Lyustikman, Y.; Momota, H.; Pao, W.; Holland, E.C. Constitutive activation of Raf-1 induces glioma formation in mice. Neoplasia 2008, 10, 501–510. [Google Scholar] [CrossRef] [Green Version]
- Papagiannakopoulos, T.; Friedmann-Morvinski, D.; Neveu, P.; Dugas, J.C.; Gill, R.M.; Huillard, E.; Liu, C.; Zong, H.; Rowitch, D.H.; Barres, B.A.; et al. Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. Oncogene 2011, 31, 1884–1895. [Google Scholar] [CrossRef] [Green Version]
- Zhang, Y.; Chao, T.; Li, R.; Liu, W.; Chen, Y.; Yan, X.; Gong, Y.; Yin, B.; Liu, W.; Qiang, B.; et al. MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J. Mol. Med. 2009, 87, 43–51. [Google Scholar] [CrossRef]
- Wuchty, S.; Arjona, D.; Li, A.; Kotliarov, Y.; Walling, J.; Ahn, S.; Zhang, A.; Marić, D.; Anolik, R.; Zenklusen, J.C.; et al. Prediction of Associations between microRNAs and Gene Expression in Glioma Biology. PLoS ONE 2011, 6, e14681. [Google Scholar] [CrossRef] [Green Version]
- Vo, D.T.; Qiao, M.; Smith, A.D.; Burns, S.C.; Brenner, A.J.; Penalva, L.O. The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs. RNA Biol. 2011, 8, 817–828. [Google Scholar] [CrossRef]
- Drosos, Y.; Kouloukoussa, M.; Østvold, A.C.; Grundt, K.; Goutas, N.; Vlachodimitropoulos, D.; Havaki, S.; Kollia, P.; Kittas, C.; Marinos, E.; et al. NUCKS overexpression in breast cancer. Cancer Cell Int. 2009, 9, 19. [Google Scholar] [CrossRef] [Green Version]
- Whitfeld, M.L.; Sherlock, G.; Saldanha, A.J.; Murray, J.I.; Ball, C.A.; Alexander, K.E.; Matese, J.C.; Perou, C.M.; Hurt, M.M.; Brown, P.O.; et al. Identifcation of genes periodically expressed in the human cell cycle and their expression in tumors. Mol. Biol. Cell 2002, 13, 1977–2000. [Google Scholar] [CrossRef] [PubMed]
- Meijer, L.; Ostvold, A.C.; Walass, S.I.; Lund, T.; Laland, S.G. High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase. Eur. J. Biochem. 1991, 196, 557–567. [Google Scholar] [CrossRef] [PubMed]
- Walaas, S.I.; Ostvold, A.C.; Laland, S.G. Phosphorylation of P1, a high mobility group-like protein, catalyzed by casein kinase II, protein kinase C, cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II. FEBS Lett. 1989, 258, 106–108. [Google Scholar] [CrossRef] [Green Version]
- Ostvold, A.C.; Norum, J.H.; Mathiesen, S.; Wanvik, B.; Sefland, I.; Grundt, K. Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. Eur. J. Biochem. 2001, 268, 2430–2440. [Google Scholar] [CrossRef] [PubMed]
- Giunti, L.; Pantaleo, M.; Sardi, I.; Provenzano, A.; Magi, A.; Cardellicchio, S.; Castiglione, F.; Tattini, L.; Novara, F.; Buccoliero, A.M.; et al. Genome-wide copy number analysis in pediatric glioblastoma multiforme. Am. J. Cancer Res. 2014, 4, 293–303. [Google Scholar]
- Lo, K.C.; Ma, C.; Bundy, B.N.; Pomeroy, S.L.; Eberhart, C.G.; Cowell, J.K. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma. Clin. Cancer Res. 2007, 13, 7022–7028. [Google Scholar] [CrossRef] [Green Version]
- Szponar, A.; Zubakov, D.; Pawlak, J.; Jauch, A.; Kovacs, G. Three genetic developmental stages of papillary renal cell tumors: Duplication of chromosome 1q marks fatal progression. Int. J. Cancer 2009, 124, 2071–2076. [Google Scholar] [CrossRef]
- Balcárková, J.; Urbánková, H.; Scudla, V.; Holzerová, M.; Bacovský, J.; Indrák, K.; Jarosová, M. Gain of chromosome arm 1q in patients in relapse and progression of multiple myeloma. Cancer Genet. Cytogenet. 2009, 192, 68–72. [Google Scholar] [CrossRef]
- Hirose, Y.; Aldape, K.; Bollen, A.; James, C.D.; Brat, D.; Lamborn, K.; Berger, M.; Feuerstein, B.G. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am. J. Pathol. 2001, 158, 1137–1143. [Google Scholar] [CrossRef] [Green Version]
- Faria, C.; Miguéns, J.; Antunes, J.L.; Salgado, D.; Nunes, S.; Barroso, C.; Martins Mdo, C.; Nunes, V.M.; Roque, L. Pediatric brain tumors: Genetics and clinical outcome. J. Neurosurg. Pediatr. 2010, 5, 263–270. [Google Scholar] [CrossRef]
- Giunti, L.; Da Ros, M.; De Gregorio, V.; Magi, A.; Landini, S.; Mazzinghi, B.; Buccoliero, A.M.; Genitori, L.; Giglio, S.; Sardi, I. A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation. Mol. Clin. Oncol. 2019, 10, 331–338. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, F.; Fu, H.; Liu, Q.; Tie, Y.; Zhu, J.; Xing, R.; Sun, Z.; Zheng, X. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008, 582, 1564–1568. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liang, M.-L.; Hsieh, T.-H.; Ng, K.-H.; Tsai, Y.-N.; Tsai, C.-F.; Chao, M.-E.; Liu, D.-J.; Chu, S.-S.; Chen, W.; Liu, Y.-R.; et al. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas. Oncotarget 2016, 7, 19723–19737. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gong, W.; Zheng, J.; Liu, X.; Ma, J.; Liu, Y.; Xue, Y. Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e. Oncotarget 2016, 7, 62208–62223. [Google Scholar] [CrossRef] [Green Version]
- Novakova, J.; Slaby, O.; Vyzula, R.; Michalek, J. MicroRNA involvement in glioblastoma pathogenesis. Biochem. Biophys. Res. Commun. 2009, 386, 1–5. [Google Scholar] [CrossRef]
- Göke, R.; Barth, P.; Schmidt, A.; Samans, B.; Lankat-Buttgereit, B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am. J. Physiol. Cell Physiol. 2004, 287, C1541–C1546. [Google Scholar] [CrossRef]
- Yang, C.H.; Yue, J.; Pfeffer, S.R.; Fan, M.; Paulus, E.; Hosni-Ahmed, A.; Sims, M.; Qayyum, S.; Davidoff, A.M.; Handorf, C.R.; et al. MicroRNA-21 Promotes Glioblastoma Tumorigenesis by Down-regulating Insulin-like Growth Factor-binding Protein-3 (IGFBP3)*. J. Boil. Chem. 2014, 289, 25079–25087. [Google Scholar] [CrossRef] [Green Version]
- Wang, P.; Liu, Y.H.; Yao, Y.L.; Li, Z.; Li, Z.Q.; Ma, J.; Xue, Y.X. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21. Cell. Signal. 2015, 27, 275–282. [Google Scholar] [CrossRef]
- Le Sage, C.; Nagel, R.; A Egan, D.; Schrier, M.; Mesman, E.; Mangiola, A.; Anile, C.; Maira, G.; Mercatelli, N.; Ciafre’, S.A.; et al. Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 2007, 26, 3699–3708. [Google Scholar] [CrossRef] [Green Version]
- Mao, J.; Zhang, M.; Zhong, M.; Zhang, Y.; Lv, K. MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion. Mol. Cell Biochem. 2014, 396, 117–128. [Google Scholar] [CrossRef]
- Song, S.; Fajol, A.; Tu, X.; Ren, B.; Shi, S. miR-204 suppresses the development and progression of human glioblastoma by targeting ATF2. Oncotarget 2016, 7, 70058–70065. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jiang, J.; Yang, J.; Wang, Z.; Wu, G.; Liu, F. TFAM is directly regulated by miR-23b in glioma. Oncol. Rep. 2013, 30, 2105–2110. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.-K.; Finniss, S.; Cazacu, S.; Bucris, E.; Ziv-Av, A.; Xiang, C.; Bobbitt, K.; Rempel, S.A.; Hasselbach, L.; Mikkelsen, T.; et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget 2013, 4, 346–361. [Google Scholar] [CrossRef] [Green Version]
- Lee, H.K.; Bier, A.; Cazacu, S.; Finniss, S.; Xiang, C.; Twito, H.; Poisson, L.M.; Mikkelsen, T.; Slavin, S.; Jacoby, E.; et al. MicroRNA-145 Is Downregulated in Glial Tumors and Regulates Glioma Cell Migration by Targeting Connective Tissue Growth Factor. PLoS ONE 2013, 8, e54652. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Speranza, M.C.; Frattini, V.; Pisati, F.; Kapetis, D.; Porrati, P.; Eoli, M.; Pellegatta, S.; Finocchiaro, G. NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma. Oncotarget 2012, 3, 723–734. [Google Scholar] [CrossRef] [Green Version]
- Ruan, J.; Lou, S.; Dai, Q.; Mao, D.; Ji, J.; Sun, X. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Neuroreport 2015, 26, 66–73. [Google Scholar] [CrossRef] [PubMed]
- Xi, Z.; Wang, P.; Xue, Y.; Shang, C.; Liu, X.; Ma, J.; Li, Z.; Li, Z.; Bao, M.; Liu, Y. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6. Oncotarget 2017, 8, 24949–24963. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, J.; Jia, Z.; Li, B.; Zhang, A.; Wang, G.; Pu, P.; Chen, Z.; Wang, Z.; Yang, W. MiR-19 regulates the proliferation and invasion of glioma by RUNX3 via β-catenin/Tcf-4 signaling. Oncotarget 2017, 8, 110785–110796. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ma, C.; Zheng, C.; Bai, E.; Yang, K. miR-101 inhibits glioma cell invasion via the downregulation of COX-2. Oncol. Lett. 2016, 12, 2538–2544. [Google Scholar] [CrossRef] [Green Version]
- Liu, N.; Zhang, L.; Wang, Z.; Cheng, Y.; Zhang, P.; Wang, X.; Wen, W.; Yang, H.; Liu, H.; Jin, W.-L.; et al. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. Oncotarget 2017, 8, 19244–19254. [Google Scholar] [CrossRef] [Green Version]
- Jin, Y.; Wang, J.; Han, J.; Luo, D.; Sun, Z. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Exp. Cell Res. 2017, 360, 210–217. [Google Scholar] [CrossRef] [PubMed]
- Zhang, F.; Wan, M.; Xu, Y.; Li, Z.; Leng, K.; Kang, P.; Cui, Y.; Jiang, X. Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/β-catenin-signaling pathway. Biomed. Pharmacother. 2017, 94, 55–62. [Google Scholar] [CrossRef] [PubMed]
- Wang, G.; Zhao, Y.; Zheng, Y. MiR-122/Wnt/beta-catenin regulatory circuitry sustains glioma progression. Tumor Biol. 2014, 35, 8565–8572. [Google Scholar] [CrossRef]
- Sun, J.; Zheng, G.; Gu, Z.; Guo, Z. MiR-137 inhibits proliferation and angiogenesis of human glioblastoma cells by targeting EZH2. J. Neuro Oncol. 2015, 122, 481–489. [Google Scholar] [CrossRef] [PubMed]
- Lan, F.; Yu, H.; Hu, M.; Xia, T.; Yue, X. miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met. J. Neurochem. 2015, 135, 274–286. [Google Scholar] [CrossRef] [PubMed]
- Zhang, P.; Sun, H.; Yang, B.; Luo, W.; Liu, Z.; Wang, J.; Zuo, Y. miR-152 regulated glioma cell proliferation and apoptosis via Runx2 mediated by DNMT1. Biomed. Pharmacother. 2017, 92, 690–695. [Google Scholar] [CrossRef] [PubMed]
- Yan, Z.; Che, S.; Wang, J.; Jiao, Y.; Wang, C.; Meng, Q. miR-155 contributes to the progression of glioma by enhancing Wnt/β-catenin pathway. Tumor Biol. 2015, 36, 5323–5331. [Google Scholar] [CrossRef]
- Zhou, Y.; Peng, Y.; Liu, M.; Jiang, Y. MicroRNA-181b Inhibits Cellular Proliferation and Invasion of Glioma Cells via Targeting Sal-Like Protein 4. Oncol. Res. 2017, 25, 947–957. [Google Scholar] [CrossRef]
- Li, P.; Lu, X.; Wang, Y.; Sun, L.; Qian, C.; Yan, W.; Liu, N.; You, Y.; Fu, Z. MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cells. J. Biomed. Res. 2010, 24, 436–443. [Google Scholar] [CrossRef] [Green Version]
- Xue, J.; Zhou, A.; Wu, Y.; Morris, S.-A.; Lin, K.; Amin, S.; Verhaak, R.; Fuller, G.N.; Xie, K.; Heimberger, A.B.; et al. miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis. Cancer Res. 2016, 76, 4293–4304. [Google Scholar] [CrossRef] [Green Version]
- Pal, D.; Mukhopadhyay, D.; Ramaiah, M.J.; Sarma, P.; Bhadra, U.; Bhadra, M.P. Regulation of Cell Proliferation and Migration by miR-203 via GAS41/miR-10b Axis in Human Glioblastoma Cells. PLoS ONE 2016, 11, e0159092. [Google Scholar] [CrossRef] [PubMed]
- Zhou, J.; Xu, T.; Yan, Y.; Qin, R.; Wang, H.; Zhang, X.; Huang, Y.; Wang, Y.; Lu, Y.; Fu, D.; et al. MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1). PLoS ONE 2013, 8, e68469. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Yang, Y.N.; Zhang, X.H.; Wang, Y.M.; Zhang, X.; Gu, Z. miR-204 reverses temozolomide resistance and inhibits cancer initiating cells phenotypes by degrading FAP-α in glioblastoma. Oncol. Lett. 2018, 15, 7563–7570. [Google Scholar] [CrossRef] [PubMed]
- Hirano, F.; Kaneko, K.; Tamura, H.; Dong, H.; Wang, S.; Ichikawa, M.; Rietz, C.; Flies, D.B.; Lau, J.S.; Zhu, G.; et al. Blockade of B7-H1 and PD-1 by monoclonal antibodies potentiates cancer therapeutic immunity. Cancer Res. 2005, 65, 1089–1096. [Google Scholar] [PubMed]
- Dong, H.; Strome, S.E.; Salomao, D.R.; Tamura, H.; Hirano, F.; Flies, D.B.; Roche, P.C.; Lu, J.; Zhu, G.; Tamada, K.; et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat. Med. 2002, 8, 793–800. [Google Scholar] [CrossRef] [PubMed]
- Mazurek, M.; Litak, J.; Kamieniak, P.; Osuchowska, I.; Maciejewski, R.; Roliński, J.; Grajkowska, W.; Grochowski, C. Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme. Int. J. Mol. Sci. 2020, 21, 1507. [Google Scholar] [CrossRef] [Green Version]
- Wintterle, S.; Schreiner, B.; Mitsdoerffer, M.; Schneider, D.; Chen, L.; Meyermann, R.; Weller, M.; Wiendl, H. Expression of the B7-related molecule B7-H1 by glioma cells: A potential mechanism of immune pa-ralysis. Cancer Res. 2003, 63, 7462–7467. [Google Scholar]
- Wang, Q.; Lin, W.; Tang, X.; Li, S.; Guo, L.; Lin, Y.; Kwok, H.F. The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint. Int. J. Mol. Sci. 2017, 18, 2540. [Google Scholar] [CrossRef] [Green Version]
- Wei, J.; Nduom, E.; Kong, L.-Y.; Hashimoto, Y.; Xu, S.; Gabrusiewicz, K.; Ling, X.; Huang, N.; Qiao, W.; Zhou, S.; et al. MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints. Neuro-Oncology 2015, 18, 639–648. [Google Scholar] [CrossRef] [Green Version]
- Zampini, M.; Bisio, V.; Leszl, A.; Putti, M.C.; Menna, G.; Rizzari, C.; Pession, A.; Locatelli, F.; Basso, G.; Tregnago, C.; et al. A three-miRNA-based expression signature at diagnosis can predict occurrence of relapse in children with t(8;21) RUNX1-RUNX1T1 acute myeloid leukaemia. Br. J. Haematol. 2018, 183, 298–301. [Google Scholar] [CrossRef] [Green Version]
- Nie, C.L.; Ren, W.H.; Ma, Y.; Xi, J.S.; Han, B. Circulating miR-125b as a biomarker of Ewing’s sarcoma in Chinese children. Genet. Mol. Res. 2015, 14, 19049–19056. [Google Scholar] [CrossRef] [PubMed]
- Lee, Y.Y.; Yang, Y.P.; Huang, M.C.; Wang, M.L.; Yen, S.H.; Huang, P.I.; Chen, Y.W.; Chiou, S.H.; Lan, Y.T.; Ma, H.I.; et al. MicroRNA142-3p promotes tumor-initiating and radioresistant properties in malignant pediatric brain tumors. Cell Transplant. 2014, 23, 669–690. [Google Scholar] [CrossRef] [PubMed]
- Uziel, T.; Karginov, F.V.; Xie, S.; Parker, J.S.; Wang, Y.D.; Gajjar, A.; He, L.; Ellison, D.; Gilbertson, R.J.; Hannon, G.; et al. The miR-17–92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc. Natl. Acad. Sci. USA 2009, 106, 2812–2817. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schulte, J.H.; Horn, S.; Otto, T.; Samans, B.; Heukamp, L.C.; Eilers, U.-C.; Krause, M.; Astrahantseff, K.; Klein-Hitpass, L.; Buettner, R.; et al. MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int. J. Cancer 2008, 122, 699–704. [Google Scholar] [CrossRef] [PubMed]
- Ferretti, E.; de Smaele, E.; Miele, E.; Laneve, P.; Po, A.; Pelloni, M.; Paganelli, A.; di Marcotullio, L.; Caffarelli, E.; Screpanti, I.; et al. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 2008, 27, 2616–2627. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Garzia, L.; Andolfo, I.; Cusanelli, E.; Marino, N.; Petrosino, G.; De Martino, D.; Esposito, V.; Galeone, A.; Navas, L.; Esposito, S.; et al. MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma. PLoS ONE 2009, 4, e4998. [Google Scholar] [CrossRef]
- Chen, Y.; Stallings, R.L. Differential patterns ofmicroRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res. 2007, 67, 976–983. [Google Scholar] [CrossRef] [Green Version]
- Ferretti, E.; De Smaele, E.; Po, A.; Di Marcotullio, L.; Tosi, E.; Espinola, M.S.B.; Di Rocco, C.; Riccardi, R.; Giangaspero, F.; Farcomeni, A.; et al. MicroRNA profiling in human medulloblastoma. Int. J. Cancer 2009, 124, 568–577. [Google Scholar] [CrossRef]
- Pierson, J.; Hostager, B.; Fan, R.; Vibhakar, R. Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma. J. Neurooncol. 2008, 90, 1–7. [Google Scholar] [CrossRef]
- Darrigo Júnior, L.G.; Lira, R.C.P.; Fedatto, P.F.; Marco Antonio, D.S.; Valera, E.T.; Aguiar, S.; Yunes, J.A.; Brandalise, S.R.; Neder, L.; Saggioro, F.P.; et al. MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter. J. Neurooncol. 2019, 141, 373–382. [Google Scholar] [CrossRef]
- Yuan, M.; Da Silva, A.C.A.L.; Arnold, A.; Okeke, L.; Ames, H.; Correa-Cerro, L.S.; Vizcaino, M.A.; Ho, C.-Y.; Eberhart, C.G.; Rodriguez, F.J. MicroRNA (miR) 125b regulates cell growth and invasion in pediatric low grade glioma. Sci. Rep. 2018, 8, 12506. [Google Scholar] [CrossRef] [PubMed]
- Bookland, M.; Tang-Schomer, M.; Gillan, E.; Kolmakova, A. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume. Acta Neurochir. 2018, 160, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Pan, L.; Meng, L.; Liang, F.; Cao, L. miR-188 suppresses tumor progression by targeting SOX4 in pediatric osteosarcoma. Mol. Med. Rep. 2018, 18, 441–446. [Google Scholar] [CrossRef] [PubMed]
- Shu, C.; Wang, Q.; Yan, X.; Wang, J. Prognostic and microRNA profile analysis for CD44 positive expression pediatric posterior fossa ependymoma. Clin. Transl. Oncol. 2018, 20, 1439–1447. [Google Scholar] [CrossRef] [PubMed]
- Catanzaro, G.; Besharat, Z.M.; Miele, E.; Chiacchiarini, M.; Po, A.; Carai, A.; Marras, C.E.; Antonelli, M.; Badiali, M.; Raso, A.; et al. The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling. Neuropathol. Appl. Neurobiol. 2018, 44, 687–706. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- López-Aguilar, J.E.; Velázquez-Flores, M.A.; Simón-Martínez, L.A.; Ávila-Miranda, R.; Rodríguez-Florido, M.A.; Ruiz-Esparza Garrido, R. Circulating microRNAs as Biomarkers for Pediatric Astrocytomas. Arch. Med. Res. 2017, 48, 323–332. [Google Scholar] [CrossRef]
- Ruiz Esparza-Garrido, R.; Rodríguez-Corona, J.M.; López-Aguilar, J.E.; Rodríguez-Florido, M.A.; Velázquez-Wong, A.C.; Viedma-Rodríguez, R.; Salamanca-Gómez, F.; Velázquez-Flores, M.Á. Differentially Expressed Long Non-Coding RNAs Were Predicted to Be Involved in the Control of Signaling Pathways in Pediatric Astrocytoma. Mol. Neurobiol. 2017, 54, 6598–6608. [Google Scholar] [CrossRef]
- Braoudaki, M.; Lambrou, G.I.; Giannikou, K.; Papadodima, S.A.; Lykoudi, A.; Stefanaki, K.; Sfakianos, G.; Kolialexi, A.; Tzortzatou-Stathopoulou, F.; Tzetis, M.; et al. miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas. Tumor Biol. 2016, 37, 9887–9897. [Google Scholar] [CrossRef]
- Feng, F.; Kuai, D.; Wang, H.; Li, T.; Miao, W.; Liu, Y.; Fan, Y. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas. Hum. Pathol. 2016, 58, 47–53. [Google Scholar] [CrossRef]
- Wu, Z.; Wang, L.; Li, G.; Liu, H.; Fan, F.; Li, Z.; Li, Y.; Gao, G. Increased expression of microRNA-9 predicts an unfavorable prognosis in human glioma. Mol. Cell. Biochem. 2013, 384, 263–268. [Google Scholar] [CrossRef]
- Liu, F.; Xiong, Y.; Zhao, Y.; Tao, L.; Zhang, Z.; Zhang, H.; Liu, Y.; Feng, G.; Li, B.; He, L.; et al. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagn. Pathol. 2013, 8, 158. [Google Scholar] [CrossRef] [Green Version]
- He, J.; Deng, Y.; Yang, G.; Xie, W. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma. J. Surg. Oncol. 2013, 108, 121–125. [Google Scholar] [CrossRef]
- Minturn, J.E.; Fisher, M.J. Gliomas in children. Curr. Treat Options Neurol. 2013, 15, 316–327. [Google Scholar] [CrossRef] [PubMed]
- Hargrave, D. Paediatric high and low grade glioma: The impact of tumour biology on current and future therapy. Br. J. Neurosurg. 2009, 23, 351–363. [Google Scholar] [CrossRef] [PubMed]
- Fangusaro, J. Pediatric high grade glioma: A review and update on tumor clinical characteristics and biology. Front. Oncol. 2012, 2, 105. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pollack, I.F.; Hamilton, R.L.; James, C.D.; Finkelstein, S.D.; Burnham, J.; Yates, A.J.; Holmes, E.J.; Zhou, T.; Finlay, J.L. Children’s Oncology Group. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: Results from the Children’s Cancer Group 945 cohort. J. Neurosurg. 2006, 105 (Suppl. 5), 418–424. [Google Scholar] [PubMed]
- Birks, D.K.; Barton, V.N.; Donson, A.M.; Handler, M.H.; Vibhakar, R.; Foreman, N.K. Survey of MicroRNA expression in pediatric brain tumors. Pediatr. Blood Cancer 2011, 56, 211–216. [Google Scholar] [CrossRef]
- Miele, E.; Buttarelli, F.R.; Arcella, A.; Begalli, F.; Garg, N.; Silvano, M.; Po, A.; Baldi, C.; Carissimo, G.; Antonelli, M.; et al. High-throughput microRNA profiling of pediatric high-grade gliomas. Neuro-Oncology 2013, 16, 228–240. [Google Scholar] [CrossRef] [Green Version]
- Jha, P.; Agrawal, R.; Pathak, P.; Kumar, A.; Purkait, S.; Mallik, S.; Suri, V.; Chand Sharma, M.; Gupta, D.; Suri, A.; et al. Genome-wide small noncoding RNA profiling of pediatric high-grade gliomas reveals deregulation of several miRNAs, identifies downregulation of snoRNA cluster HBII-52 and delineates H3F3A and TP53 mutant-specific miRNAs and snoRNAs. Int. J. Cancer 2015, 137, 2343–2353. [Google Scholar] [CrossRef]
- Paugh, B.S.; Qu, C.; Jones, C.; Liu, Z.; Adamowicz-Brice, M.; Zhang, J.; Bax, D.A.; Coyle, B.; Barrow, J.; Hargrave, D.; et al. Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J. Clin. Oncol. 2010, 28, 3061–3068. [Google Scholar] [CrossRef]
- Louis, D.N.; Ohgaki, H.; Wiestler, O.D.; Cavenee, W.K.; Burger, P.C.; Jouvet, A.; Scheithauer, B.W.; Kleihues, P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114, 97–109. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pollack, I.F.; Boyett, J.M.; Yates, A.J.; Burger, P.C.; Gilles, F.H.; Davis, R.L.; Finlay, J.L. Children’s Cancer Group: The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience. Neuro Oncol. 2003, 5, 197–207. [Google Scholar] [CrossRef] [PubMed]
- Nakamura, M.; Shimada, K.; Ishida, E.; Higuchi, T.; Nakase, H.; Sakaki, T.; Konishi, N. Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol. 2007, 9, 113–123. [Google Scholar] [CrossRef] [PubMed]
- Ohgaki, H.; Kleihues, P. Genetic pathways to primary and secondary glioblastoma. Am. J. Pathol. 2007, 170, 1445–1453. [Google Scholar] [CrossRef] [Green Version]
- Pollack, I.F.; Finkelstein, S.D.; Woods, J.; Burnham, J.; Holmes, E.J.; Hamilton, R.L.; Yates, A.J.; Boyett, J.M.; Finlay, J.L.; Sposto, R. Children’s Cancer Group: Expression of p53 and prognosis in children with malignant gliomas. N. Engl. J. Med. 2002, 346, 420–427. [Google Scholar] [CrossRef]
- Ganigi, P.M.; Santosh, V.; Anandh, B.; Chandramouli, B.A.; Sastry Kolluri, V.R. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: A study of 54 patients. Pediatr. Neurosurg. 2005, 41, 292–299. [Google Scholar] [CrossRef] [PubMed]
- Gómez Del Pulgar, T.; De Ceballos, M.L.; Guzmán, M.; Velasco, G. Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 2002, 277, 36527–36533. [Google Scholar] [CrossRef] [Green Version]
- King, D.; Yeomanson, D.; Bryant, H.E. PI3King the lock: Targeting the PI3K/Akt/mTOR pathway as a novel therapeutic strategy in neuroblastoma. J. Pediatr. Hematol. Oncol. 2015, 37, 245–251. [Google Scholar] [CrossRef]
- Ojeda, L.; Gao, J.; Hooten, K.G.; Wang, E.; Thonhoff, J.R.; Dunn, T.J.; Gao, T.; Wu, P. Critical Role of PI3K/Akt/GSK3β in Motoneuron Specification from Human Neural Stem Cells in Response to FGF2 and EGF. PLoS ONE 2011, 6, e23414. [Google Scholar] [CrossRef]
- Rizzo, D.; Ruggiero, A.; Martini, M.; Rizzo, V.; Maurizi, P.; Riccardi, R. Molecular Biology in Pediatric High-Grade Glioma: Impact on Prognosis and Treatment. Biomed Res. Int. 2015, 2015, 215135. [Google Scholar] [CrossRef] [Green Version]
- Rafalski, V.A.; Brunet, A. Energy metabolism in adult neural stem cell fate. Prog. Neurobiol. 2011, 93, 182–203. [Google Scholar] [CrossRef] [PubMed]
- Chu, E.C.; Tarnawski, A.S. PTEN regulatory functions in tumor suppression and cell biology. Med. Sci. Monit. 2004, 10, RA235–RA241. [Google Scholar] [PubMed]
- Hopkins, B.D.; Hodakoski, C.; Barrows, D.; Mense, S.M.; Parsons, R.E. PTEN function: The long and the short of it. Trends Biochem. Sci. 2014, 39, 183–190. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Smith, J.S.; Tachibana, I.; Passe, S.M.; Huntley, B.K.; Borell, T.J.; Iturria, N.; O’Fallon, J.R.; Schaefer, P.L.; Scheithauer, B.W.; James, C.D.; et al. PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J. Natl. Cancer Inst. 2001, 93, 1246–1256. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kraus, J.A.; Felsberg, J.; Tonn, J.C.; Reifenberger, G.; Pietsch, T. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood. Neuropathol. Appl. Neurobiol. 2002, 28, 325–333. [Google Scholar] [CrossRef] [PubMed]
- Raffel, C.; Frederick, L.; O’Fallon, J.R.; Atherton-Skaff, P.; Perry, A.; Jenkins, R.B.; James, C.D. Analysis of oncogene and tumor suppressor gene alterations in pediatric malignant astrocytomas reveals reduced survival for patients with PTEN mutations. Clin. Cancer Res. 1999, 5, 4085–4090. [Google Scholar] [PubMed]
- Bax, D.A.; Mackay, A.; E Little, S.; Carvalho, D.; Viana-Pereira, M.; Tamber, N.; Grigoriadis, A.; Ashworth, A.; Reis, R.M.; Ellison, D.W.; et al. A Distinct Spectrum of Copy Number Aberrations in Pediatric High-Grade Gliomas. Clin. Cancer Res. 2010, 16, 3368–3377. [Google Scholar] [CrossRef] [Green Version]
- Jones, C.; Perryman, L.; Hargrave, D. Paediatric and adult malignant glioma: Close relatives or distant cousins? Nat. Rev. Clin. Oncol. 2012, 9, 400–413. [Google Scholar] [CrossRef]
- Zhang, C.-Z.; Han, L.; Zhang, A.-L.; Fu, Y.C.; Xiao, Y.; Wang, G.-X.; Jia, Z.-F.; Pu, P.-Y.; Zhang, Q.-Y.; Kang, C.-S. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010, 10, 367. [Google Scholar]
- Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S.T.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133, 647–658. [Google Scholar] [CrossRef] [Green Version]
- Kim, H.; Huang, W.; Jiang, X.; Pennicooke, B.; Park, P.J.; Johnson, M.D. Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc. Natl. Acad. Sci. USA 2010, 107, 2183–2188. [Google Scholar] [CrossRef] [Green Version]
- Olive, V.; Jiang, I.; He, L. mir-17–92, a cluster of miRNAs in the midst of the cancer network. Int. J. Biochem. Cell Biol. 2010, 42, 1348–1354. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murphree, A.L.; Benedict, W. Retinoblastoma: Clues to human oncogenesis. Science 1984, 223, 1028–1033. [Google Scholar] [CrossRef] [PubMed]
- Ingham, P.W.; Nakano, Y.; Seger, C. Mechanisms and functions of Hedgehog signalling across the metazoa. Nat. Rev. Genet. 2011, 12, 393–406. [Google Scholar] [CrossRef]
- Clement, V.; Sanchez, P.; de Tribolet, N.; Radovanovic, I.; Ruiz i Altaba, A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007, 17, 165–172. [Google Scholar] [CrossRef] [PubMed]
- Dahmane, N.; Sánchez, P.; Gitton, Y.; Palma, V.; Sun, T.; Beyna, M.; Weiner, H.; I Altaba, A.R. The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001, 128, 5201–5212. [Google Scholar]
- Northcott, P.A.; Fernandez, L.A.; Hagan, J.P.; Ellison, D.W.; Grajkowska, W.; Gillespie, Y.; Grundy, R.; Van Meter, T.; Rutka, J.T.; Croce, V.; et al. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 2009, 69, 3249–3255. [Google Scholar] [CrossRef] [Green Version]
- Williams, L.T. Signal transduction by the platelet-derived growth factor receptor. Science 1989, 243, 1564–1570. [Google Scholar] [CrossRef]
- Sung, T.; Miller, D.C.; Hayes, R.L.; Alonso, M.; Yee, H.; Newcomb, E.W. Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas. Brain Pathol. 2000, 10, 249–259. [Google Scholar] [CrossRef]
- Puget, S.; Philippe, C.; Bax, D.A.; Job, B.; Varlet, P.; Junier, M.-P.; Andreiuolo, F.; Carvalho, D.; Reis, R.; Guerrini-Rousseau, L.; et al. Mesenchymal Transition and PDGFRA Amplification/Mutation Are Key Distinct Oncogenic Events in Pediatric Diffuse Intrinsic Pontine Gliomas. PLoS ONE 2012, 7, e30313. [Google Scholar] [CrossRef] [Green Version]
- Sturm, D.; Witt, H.; Hovestadt, V.; Quang, D.A.K.; Jones, D.T.W.; Konermann, C.; Pfaff, E.; Tönjes, M.; Sill, M.; Bender, S.; et al. Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma. Cancer Cell 2012, 22, 425–437. [Google Scholar] [CrossRef] [PubMed]
- Libermann, T.A.; Nusbaum, H.R.; Razon, N.; Kris, R.; Lax, I.; Soreq, H.; Whittle, N.; Waterfield, M.D.; Ullrich, A.; Schlessinger, J. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 1985, 313, 144–147. [Google Scholar] [CrossRef] [PubMed]
- Erlandsson, A.; Enarsson, M.; Forsberg-Nilsson, K. Immature neurons from CNS stem cells proliferate in response to platelet-derived growth factor. J. Neurosci. 2001, 21, 3483–3491. [Google Scholar] [CrossRef] [PubMed]
- Wang, D.; Huang, H.J.; Kazlauskas, A.; Cavenee, W.K. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. Cancer Res. 1999, 59, 1464–1472. [Google Scholar]
- Holland, E.C.; Hively, W.P.; DePinho, R.A.; Varmus, H.E. A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice. Genes Dev. 1998, 12, 3675–3685. [Google Scholar] [CrossRef] [Green Version]
- Ding, H.; Shannon, P.; Lau, N.; Wu, X.; Roncari, L.; Baldwin, R.L.; Takebayashi, H.; Nagy, A.; Gutmann, D.H.; Guha, A. Oligodendrogliomas result from the expression of an activated mutant epidermal growth factor receptor in a RAS transgenic mouse astrocytoma model. Cancer Res. 2003, 63, 1106–1113. [Google Scholar]
- Tchougounova, E.; Kastemar, M.; Bråsäter, D.; Holland, E.C.; Westermark, B.; Uhrbom, L. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma. Oncogene 2007, 26, 6289–6296. [Google Scholar] [CrossRef] [Green Version]
- Lindberg, N.; Kastemar, M.; Olofsson, T.; Smits, A.; Uhrbom, L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 2009, 28, 2266–2275. [Google Scholar] [CrossRef] [Green Version]
- Yang, Y.; Dodbele, S.; Park, T.; Glass, R.; Bhat, K.; Sulman, E.P.; Zhang, Y.; Abounader, R. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway. J. Neurooncol. 2019, 145, 23–34. [Google Scholar] [CrossRef]
- Costa, P.M.; Cardoso, A.L.; Pereira de Almeida, L.F.; Bruce, J.N.; Canoll, P.; Pedroso de Lima, M.C. PDGF-B-mediated downregulation of miR-21: New insights into PDGF signaling in glioblastoma. Hum. Mol. Genet. 2012, 21, 5118–5130. [Google Scholar] [CrossRef] [Green Version]
- Dang, L.; White, D.W.; Gross, S.; Bennett, B.D.; Bittinger, M.A.; Driggers, E.M.; Fantin, V.R.; Jang, H.G.; Jin, S.; Keenan, M.C.; et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462, 739–744. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Eckel-Passow, J.E.; Lachance, D.H.; Molinaro, A.M.; Walsh, K.M.; Decker, P.A.; Sicotte, H.; Pekmezci, M.; Rice, T.; Kosel, M.L.; Smirnov, I.V.; et al. Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors. N. Engl. J. Med. 2015, 372, 2499–2508. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Halatsch, M.E.; Löw, S.; Hielscher, T.; Schmidt, U.; Unterberg, A.; Vougioukas, V.I. Epidermal growth factor receptor pathway gene expressions and biological response of glioblastoma multiforme cell lines to erlotinib. Anticancer Res. 2008, 28, 3725–3728. [Google Scholar] [PubMed]
- Antonelli, M.; Buttarelli, F.R.; Arcella, A.; Nobusawa, S.; Donofrio, V.; Oghaki, H.; Giangaspero, F. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J. Neurooncol. 2010, 99, 209–215. [Google Scholar] [CrossRef] [PubMed]
- Yan, H.; Parsons, D.W.; Jin, G.; McLendon, R.; Rasheed, B.A.; Yuan, W.; Kos, I.; Batinic-Haberle, I.; Jones, S.; Riggins, G.J.; et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 2009, 360, 765–773. [Google Scholar] [CrossRef]
- Setty, P.; Hammes, J.; Rothämel, T.; Vladimirova, V.; Kramm, C.M.; Pietsch, T.; Waha, A. A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples. J. Mol. Diagn. 2010, 12, 750–756. [Google Scholar] [CrossRef]
- Schiffman, J.D.; Hodgson, J.G.; Vandenberg, S.R.; Flaherty, P.; Polley, M.-Y.C.; Yu, M.; Fisher, P.; Rowitch, D.H.; Ford, J.M.; Berger, M.S.; et al. Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res. 2010, 70, 512–519. [Google Scholar] [CrossRef] [Green Version]
- De Carli, E.; Wang, X.; Puget, S. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 2009, 360, 2248–2249. [Google Scholar] [CrossRef] [Green Version]
- Balss, J.; Meyer, J.; Mueller, W.; Korshunov, A.; Hartmann, C.; von Deimling, A. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 2008, 116, 597–602. [Google Scholar] [CrossRef]
- Haque, T.; Faury, D.; Albrecht, S.; Lopez-Aguilar, E.; Hauser, P.; Garami, M.; Hanzely, Z.; Bognár, L.; Del Maestro, R.F.; Atkinson, J.; et al. Gene Expression Profiling from Formalin-Fixed Paraffin-Embedded Tumors of Pediatric Glioblastoma. Clin. Cancer Res. 2007, 13, 6284–6292. [Google Scholar] [CrossRef] [Green Version]
- Johnson, R.; Wright, K.D.; Gilbertson, R.J. Molecular profiling of pediatric brain tumors: Insight into biology and treatment. Curr. Oncol. Rep. 2009, 11, 68–72. [Google Scholar] [CrossRef] [PubMed]
- Jha, P.; Patric, I.R.P.; Shukla, S.; Pathak, P.; Pal, J.; Sharma, V.; Thinagararanjan, S.; Santosh, V.; Suri, V.; Sharma, M.C.; et al. Genome-wide methylation profiling identifies an essential role of reactive oxygen species in pediatric glioblastoma multiforme and validates a methylome specific for H3 histone family 3A with absence of G-CIMP/isocitrate dehydrogenase 1 mutation. Neuro-Oncology 2014, 16, 1607–1617. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Parsons, D.W.; Jones, S.; Zhang, X.; Lin, J.C.-H.; Leary, R.J.; Angenendt, P.; Mankoo, P.; Carter, H.; Siu, I.-M.; Gallia, G.L.; et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 2008, 321, 1807–1812. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ichimura, K.; Pearson, D.M.; Kocialkowski, S.; Bäcklund, L.M.; Chan, R.; Jones, D.T.; Collins, V.P. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol. 2009, 11, 341–347. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hartmann, C.; Meyer, J.; Balss, J.; Capper, D.; Mueller, W.; Christians, A.; Felsberg, J.; Wolter, M.; Mawrin, C.; Wick, W.; et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas. Acta Neuropathol. 2009, 118, 469–474. [Google Scholar] [CrossRef] [Green Version]
- Pollack, I.F.; Hamilton, R.L.; Sobol, R.W.; Nikiforova, M.N.; Lyons-Weiler, M.A.; LaFramboise, W.A.; Burger, P.C.; Brat, D.J.; Rosenblum, M.K.; Holmes, E.J.; et al. IDH1 mutations are common in malignant gliomas arising in adolescents: A report from the Children’s Oncology Group. Child’s Nerv. Syst. 2010, 27, 87–94. [Google Scholar] [CrossRef] [Green Version]
- Wang, Z.; Bao, Z.; Yan, W.; You, G.; Wang, Y.; Li, X.; Zhang, W. Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type. J. Exp. Clin. Cancer Res. 2013, 32, 59. [Google Scholar] [CrossRef] [Green Version]
- Simon, J.A.; Kingston, R.E. Mechanisms of polycomb gene silencing: Knowns and unknowns. Nat. Rev. Mol. Cell Biol. 2009, 10, 697–708. [Google Scholar] [CrossRef]
- Gielen, G.H.; Gessi, M.; Hammes, J.; Kramm, C.M.; Waha, A.; Pietsch, T. H3F3A K27M mutation in pediatric CNS tumors: A marker for diffuse high-grade astrocytomas. Am. J. Clin. Pathol. 2013, 139, 345–349. [Google Scholar] [CrossRef] [Green Version]
- Khuong-Quang, N.-A.; Buczkowicz, P.; Rakopoulos, P.; Liu, X.-Y.; Fontebasso, A.M.; Bouffet, E.; Bartels, U.; Albrecht, S.; Schwartzentruber, J.; Letourneau, L.; et al. K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol. 2012, 124, 439–447. [Google Scholar] [CrossRef] [Green Version]
- Wu, G.; Broniscer, A.; McEachron, T.A.; Lu, C.; Paugh, B.S.; Becksfort, J.; Qu, C.; Ding, L.; Huether, R.; Parker, M.; et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 2012, 44, 251–253. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schwartzentruber, J.; Korshunov, A.; Liu, X.-Y.; Jones, D.T.W.; Pfaff, E.; Jacob, K.; Sturm, D.; Fontebasso, A.M.; Quang, D.A.K.; Tönjes, M.; et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482, 226–231. [Google Scholar] [CrossRef] [PubMed]
- Jha, P.; Suri, V.; Singh, G.; Jha, P.; Purkait, S.; Pathak, P.; Sharma, V.; Sharma, M.C.; Suri, A.; Gupta, D.; et al. Characterization of Molecular Genetic Alterations in GBMs Highlights a Distinctive Molecular Profile in Young Adults. Diagn. Mol. Pathol. 2011, 20, 225–232. [Google Scholar] [CrossRef] [PubMed]
- Ganci, F.; Sacconi, A.; Ben-Moshe, N.B.; Manciocco, V.; Sperduti, I.; Strigari, L.; Covello, R.; Benevolo, M.; Pescarmona, E.; Domany, E.; et al. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients. Ann. Oncol. 2013, 24, 3082–3088. [Google Scholar] [CrossRef] [PubMed]
- Chu, S.H.; Ma, Y.B.; Feng, D.F.; Li, Z.Q.; Jiang, P.C. Correlation between satb1 and Bcl-2 expression in human glioblastoma multiforme. Mol. Med. Rep. 2013, 7, 139–143. [Google Scholar] [CrossRef] [Green Version]
- Verginelli, F.; Perin, A.; Dali, R.; Fung, K.H.; Lo, R.; Longatti, P.; Guiot, M.-C.; Del Maestro, R.F.; Rossi, S.; Di Porzio, U.; et al. Transcription factors FOXG1 and Groucho/TLE promote glioblastoma growth. Nat. Commun. 2013, 4, 2956. [Google Scholar] [CrossRef] [Green Version]
- D’Urso, P.I.; D’Urso, O.F.; Storelli, C.; Mallardo, M.; Gianfreda, C.D.; Montinaro, A.; Cimmino, A.; Pietro, C.; Marsigliante, S. miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int. J. Oncol. 2012, 41, 228–234. [Google Scholar]
- Wang, Q.; Wang, L.; Li, D.; Deng, J.; Zhao, Z.; He, S.; Zhang, Y.; Tu, Y. Kinesin family member 14 is a candidate prognostic marker for outcome of glioma patients. Cancer Epidemiol. 2013, 37, 79–84. [Google Scholar] [CrossRef]
- Corson, T.W.; Gallie, B.L. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer. Int. J. Cancer 2006, 119, 1088–1094. [Google Scholar] [CrossRef]
- Thériault, B.L.; Pajovic, S.; Bernardini, M.Q.; Shaw, P.A.; Gallie, B.L. Kinesin family member 14: An independent prognostic marker and potential therapeutic target for ovarian cancer. Int. J. Cancer 2012, 130, 1844–1854. [Google Scholar] [CrossRef]
- Corson, T.W.; Zhu, C.Q.; Lau, S.K.; Shepherd, F.A.; Tsao, M.S.; Gallie, B.L. KIF14 messenger RNA expression is independently prognostic for outcome in lung cancer. Clin. Cancer Res. 2007, 13, 3229–3234. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chung, V.; Heath, E.I.; Schelman, W.R.; Johnson, B.M.; Kirby, L.C.; Lynch, K.M.; Botbyl, J.D.; Lampkin, T.A.; Holen, K.D. First-time-in-human study of GSK923295, a novel antimitotic inhibitor of centromere-associated protein E (CENP-E), in patients with refractory cancer. Cancer Chemother. Pharmacol. 2012, 69, 733–741. [Google Scholar] [CrossRef] [PubMed]
- Liu, Z.-J.; Ling, K.; Wu, X.; Cao, J.; Liu, B.; Li, S.; Shi, Q.; Cai, Y.; Yan, C.; Zhang, Y.; et al. Reduced expression of cenp-e in human hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 2009, 28, 156. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agarwal, R.; Gonzalez-Angulo, A.-M.; Myhre, S.; Carey, M.; Lee, J.-S.; Overgaard, J.; Alsner, J.; Stemke-Hale, K.; Lluch, A.; Neve, R.M.; et al. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer. Clin. Cancer Res. 2009, 15, 3654–3662. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Apoptosis (Tissue Level) | Invasiveness (Tissue Level) | Angiogenesis (Tissue Level) | Proliferation (Tissue Level) | Biomarkers (Tissue Level) | Histological Progression (Tissue Level) | Treatment Response (Tissue Level) |
---|---|---|---|---|---|---|
miR-10b ↓ miR-21 ↓ miR-34a ↑ miR-124 ↓ miR-182 ↑ miR-211 ↑ miR-221 ↑ miR-222 ↑ miR-326 ↓ miR-330 ↓ miR-335 ↓ | miR-7 ↑ miR-10b ↑ miR-21 ↑ miR-29 ↑ miR-34a ↑ miR-107 ↑ miR-142 ↑ miR-146 ↓ miR-146b-5p ↑ miR-181b ↓ miR-181c ↓ miR-200 ↑ miR-203 ↓ miR-204 ↑ miR-655 ↓ | miR-7-5p ↓ miR-17-5p ↓ miR-21 ↑ miR-29a ↓ miR-93 ↑ miR-125b ↓ miR-128 ↓ miR-155 ↓ miR-186 ↓ miR-210-3p ↑ miR-296 ↑ miR-429 ↓ miR-675-5p ↓ | miR-7 ↑↓ miR-19a ↑↓ miR-21 ↑ miR-23 ↑↓ miR-29 ↑↓ miR-34 ↑↓ miR-101 ↑↓ miR-107 ↑↓ miR-122 ↑↓ miR-124 ↓ miR-128 ↓ miR-137 ↓ miR-140 ↑↓ miR-144 ↑↓ miR-145 ↑↓ miR-152 ↑↓ miR-155 ↑↓ miR-181 ↑↓ miR-181c ↑↓ miR-182 ↑↓ miR-186 ↑↓ miR-203 ↑↓ miR-204 ↑↓ miR-221 ↑↓ miR-222 ↑↓ miR-326 ↑↓ miR-384 ↑↓ miR-6500-3p ↑↓ | miR-17 ↑ miR-19a ↑ miR-19b ↑ miR-21 ↑ miR-25 ↑ miR-34a ↓ miR-92b ↑ miR-106b ↑ miR-125b ↑ miR-128a ↓ miR-130a ↑ miR-132 ↓ miR-155 ↑ miR-181a ↓ miR-181b ↓ miR-181c ↓ miR-182 ↑ miR-198 ↓ miR-219-5p ↓ miR-221 ↑ miR-329 ↓ miR-335 ↑ miR-338-3p ↓ miR-483-5p ↓ | miR-9 ↑ miR-15a ↑ miR-16 ↑ miR-17 ↑ miR-19a ↑ miR-20a ↑ miR-21 ↑ miR-25 ↑ miR-28 ↑ miR-130b ↑ miR-140 ↑ miR-184 ↑ miR-210 ↑ miR-328 ↑ | miR-17-5p ↑↓ miR-21 ↑ miR-19a ↑↓ miR-19b ↑↓ miR-100 ↑ miR-101 ↓ miR-139 ↑↓ miR-143 ↑ miR-155 ↑ miR-181a ↓ miR-182 ↑↓ miR-193a5p ↑↓ miR-200a ↑↓ miR-200q ↑↓ miR-203 ↑↓ miR-204 ↑↓ miR-221 ↑↓ miR-222 ↑↓ miR-328 ↑↓ miR-490 ↑↓ miR-603 ↑↓ miR-873 ↑↓ |
Overexpression | Reduced Expression |
---|---|
miR-15a miR-17 miR-18a miR-19a miR-19b miR-20 miR-27a miR-92 miR-100 miR-106a miR-195 miR-497 | miR-7-5p miR-124-5p miR-129-2-3p miR-137 miR-138-2-3p miR-139-3p miR-203a miR-218-5p miR-329-3p miR-770-5p |
Overexpression | Reduced Expression |
---|---|
miR-10b miR-21 miR-25 miR-26a miR-221 miR-222 miR-335 miR-451 miR-486 miR-501-3p | miR-7 miR-106a miR-124 miR-128 miR-129 miR-137 miR-139 miR-181a miR-181b miR-218 miR-323 miR-328 |
Overexpression | Reduced Expression |
---|---|
miR-17-5p | miR-137 |
miR-561-5p | miR-6500-3p |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mazurek, M.; Grochowski, C.; Litak, J.; Osuchowska, I.; Maciejewski, R.; Kamieniak, P. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme. Int. J. Mol. Sci. 2020, 21, 3046. https://doi.org/10.3390/ijms21093046
Mazurek M, Grochowski C, Litak J, Osuchowska I, Maciejewski R, Kamieniak P. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme. International Journal of Molecular Sciences. 2020; 21(9):3046. https://doi.org/10.3390/ijms21093046
Chicago/Turabian StyleMazurek, Marek, Cezary Grochowski, Jakub Litak, Ida Osuchowska, Ryszard Maciejewski, and Piotr Kamieniak. 2020. "Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme" International Journal of Molecular Sciences 21, no. 9: 3046. https://doi.org/10.3390/ijms21093046